|Therapeutic Area||Formulary Choices||Cost for 28|
(unless otherwise stated)
|Rationale for decision / comments|
|Women requiring contraception should be given information about and offered a choice of all methods including LARC (long-acting reversible contraception).|
The effectiveness of combined oral contraceptives, progestogen-only oral contraceptives, contraceptive patches, and vaginal rings can be considerably reduced by interaction with drugs that induce hepatic enzyme activity (e.g. carbamazepine, eslicarbazepine, modafinil, nelfinavir, nevirapine, oxcarbazepine, phenytoin, phenobarbital, primidone, ritonavir, St John’s Wort, topiramate, and, above all, rifabutin and rifampicin).
Hormonal contraceptives and antibacterials that do not induce liver enzymes
Advice on interactions between combined hormonal contraceptives and antibacterials that do not induce liver enzymes has been updated to take into account the recommendations of the Faculty of Sexual and Reproductive Healthcare Clinical Guidance: Drug Interactions with Hormonal Contraception (January 2011).
Additional contraceptive precautions are no longer necessary when antibacterials that do not induce liver enzymes are taken with combined oral contraceptives, (unless diarrhoea or vomiting occurs), contraceptive patches or vaginal rings. Click here for more information.
Some other interactions of hormonal contraceptives have been updated in Appendix 1 of the BNF: Interactions (under Oestrogens and Progestogens)
|7.3.1 Combined hormonal contraceptives|
|Low strength||Ethinylestradiol / norethisterone |
as Loestrin 20®
|20mcg/1mg tablets: £2.30 (63)|
|Ethinylestradiol / drospirenone |
|20mcg/3mg tablets: £14.70 (84)|
|Standard strength:||Ethinylestradiol / norgestrel |
|30mcg/150mcg tablets: £1.89 (63)|
30mcg/150mcg tablets: £2.20 (63)
|Rigevidon® is a cost-effective alternative to Microgynon 30® and Ovranette®.|
|Ethinylestradiol / norgestimate|
|35mcg/250mcg tablets: £7.16 (63)|
35mcg/250mcg tablets: £4.65 (63)
35mcg/250mcg tablets: £5.37 (63)
|Ethinylestradiol / gestodene |
as Millinette® 20/75
as Millinette® 30/75
|20mcg/75mcg tablets: £5.41 (63)|
30mcg/75mcg tablets: £4.12 (63)
|NB: Third-generation COCs containing the progestogens gestodene or desogestrel (e.g. Femodene®) are associated with a higher risk of VTE.
Millinette® 30/75 is a cost-effective alternative to Femodene®
|Ethinylestradiol / norethisterone (tri phasic) as Tri-Novum®||35mcg/500mcg, |
35mcg/1mg: £3.46 (63)
|Ethinylestradiol / drospirenone |
|30mcg/3mg: £9.35 (63)|
30mcg/3mg: £8.30 (63)
30mcg/3mg: £8.30 (63)
|Cost effective equivalent to Yasmin®|
|7.3.2 Progestogen-only contraceptives (POPs)||Norethisterone 350mcg||Tablets: £4.50 (84)||Progestogens gestodene or desogestrel (e.g. Cerelle® ) are associated with a higher risk of VTE.
|126.96.36.199 Intra uterine POP system||Mirena®|
|T-shaped plastic frame levonorgestrel 20 micrograms/24 hours, net price = £88.00|
|Five year use license
Smaller frame and smaller reservoir. Approved for use in the CASH service where a coil is appropriate but Mirena is not suitable or not tolerated. Three year life license. Contraception only
|Long-acting reversible contraception |
|LARC methods are more cost-effective than COC pill even at one year.
Please see NICE guidance on Features of the larc methods to discuss with women (Sept 14) and Choice of method for different groups of women (Sept 14)
as Sayana Press®
|150mg/ml prefilled syringe: £6.01 (1)|
104mg/0.65ml susp in pre-filled injector, 1=£6.90.
|68mg implant: £83.43||Nexplanon® is bioequivalent to Implanon® (discontinued); it has the same release rate and 3-year duration of action. Nexplanon® also has a different application device and insertion technique. Please visit http://www.nexplanontraining.co.uk/ or contact SDM directly for training.|
|7.3.5 Emergency Hormonal Contraception (EHC)||Levonorgestrel 1500mcg tablet |
|1500mcg tablet: £3.75 (1)||Available via PGD through many pharmacies across Somerset, free of charge to all.
Levonorgestrol 1500mcg is the first-line oral preparation for patients presenting within 72 hours of UPSI or contraceptive failure.
DO NOT PRESCRIBE AS THE OTC PREPARATION: Levonelle One Step® (as over twice the cost of the POM product.)
|Ulipristal acetate 30mg tablet ▼|
|30mg tablet: £14.05 (1)||Patients presenting between 72 hours and 120 hours may be offered the choice of ulipristal acetate or intrauterine device and the risks and benefits of each method should be discussed with the patient.
Ulipristal is licensed for emergency contraception within 120 hours (5 days) after unprotected sexual intercourse (UPSI).
Pregnancy should be excluded before ulipristal is taken.
|Please note that patients who have a BMI >26 or are greater than 70kg may require more than the standard 1.5mg dose of levonorgestrel.
Consider double dose (3mg) or CI-IUD or ulipristal.Link
Women taking enzyme inducing medication may require further measures. EC providers should advise women using enzyme-inducing drugs that the
effectiveness of UPA-EC and LNG-EC could be reduced.
Women requiring EC who are using enzyme-inducing drugs should be offered a Cu-IUD if appropriate. A 3 mg dose of LNG can be considered but women should
be informed that the effectiveness of this regimen is unknown. A double-dose of UPA-EC is not recommended.
Link to FSRH guideline
|Pre-operative treatment of uterine fibroids||Ulipristal acetate 5mg tablet |
|5mg tablet: £ 114.13 (28)||Ulipristal acetate is indicated for pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age over the age of 18.
Approved at Somerset Prescribing Forum as an AMBER drug for a maximum of 3 months treatment only with the acute trust to supply the first month.
Also for intermittant treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. Up to four intermittant cycles can be given and may be an option to reduce the need for surgery in some women.
Pregnancy should be precluded prior to treatment and a non hormonal contraceptive method is recommended during treatment